First Report ofSchistosoma mekongiInfection with Brain Involvement
Authors:
- 1 January 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (1) , e1-e6
Abstract
We describe, to our knowledge, the first reported case of Schistosoma mekongi infection with brain involvement. S. mekongi is a distinct species most closely related to Schistosoma japonicum that is endemic in a defined area of the Mekong River in Laos and Cambodia and characteristically associated with hepatosplenic disease. The patient had an excellent response to praziquantel therapy but required repeated courses of corticosteroid therapy to suppress recrudescent neurological symptoms.Keywords
This publication has 21 references indexed in Scilit:
- NeuroschistosomiasisBrain Pathology, 1997
- Spinal and Cerebral SchistosomiasisSeminars in Neurology, 1993
- Phenytoin and carbamazepine decrease oral bioavailability of praziquantelNeurology, 1992
- SPINAL CORD SCHISTOSOMIASISBrain, 1991
- Effect of praziquantel on the eggs ofSchistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasisPathogens and Global Health, 1989
- Plasma levels of praziquantel decrease when dexamethasone is given simultaneouslyNeurology, 1987
- PRAZIQUANTEL IN TREATMENT OF CEREBRAL SCHISTOSOMIASISThe Lancet, 1986
- Treatment of Schistosoma mekongi with praziquantel in Cambodian refugees in holding centres in Prachinburi province, ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1984
- The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetateTransactions of the Royal Society of Tropical Medicine and Hygiene, 1980
- SCHISTOSOMIASIS OF THE CENTRAL NERVOUS SYSTEMArchives of Neurology And Psychiatry, 1948